Cargando…
Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?
Idiopathic pulmonary fibrosis is a rare, life threatening disease characterized by an anarchic fibrogenesis, limited survival and few therapeutic options. Its pathogenesis is complex and involves the interaction among various pathways driven by proinflammatory/profibrogenetic mediators such as plate...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541099/ https://www.ncbi.nlm.nih.gov/pubmed/23146151 http://dx.doi.org/10.1186/2049-6958-7-41 |